Hormone Therapy Before Facelift Surgery: Route, VTE Risk and Travel
Hormone replacement therapy should not be stopped automatically before every facelift. The plan depends on the hormone, route, dose, reason for treatment, personal clot risk, operation length and international travel. Oral, transdermal and local preparations do not create identical systemic exposure.
Which details change the decision?
| Factor | Why it matters |
|---|---|
| Oral versus transdermal estrogen | Observed VTE associations differ by route |
| Estrogen alone or combined treatment | Formulation and progestogen may affect risk |
| Previous DVT, PE or thrombophilia | Raises concern beyond hormone use alone |
| Procedure extent and mobility | Longer operations and reduced mobility add risk |
| Long-haul flights | Prolonged sitting adds another exposure |
Patients should send a photograph of the packaging, exact dose, route and prescribing indication. “Hormones” is not enough information for perioperative planning.
What does the evidence show?
Observational research generally associates oral menopausal hormone therapy with more VTE than transdermal therapy. A large nested case-control study of women aged 50–64 found higher VTE odds with oral than transdermal exposure. This does not prove that a patch is risk-free or that changing route immediately before surgery is appropriate.
The evidence on stopping HRT specifically before surgery remains limited. A 2026 scoping review found sparse direct comparative data and inconsistent guidance. That uncertainty argues for individualized assessment, not a universal instruction.
Stopping treatment also has consequences
Hot flashes, insomnia, mood symptoms, joint discomfort and genitourinary symptoms may return after interruption. Poor sleep and distress can complicate surgical preparation and recovery. If treatment is paused, the prescriber should define how and when it will be restarted.
Combined hormonal contraception is a separate issue. Stopping it without an alternative can create pregnancy risk, which changes the safety of elective surgery and anesthesia.
Travel and surgery must be assessed together
Long flights, recent surgery, reduced mobility, obesity, smoking, previous VTE and estrogen exposure can accumulate. Patients should not self-prescribe aspirin, anticoagulants or compression garments as a substitute for medical assessment.
When risk is uncertain, the team may request input from the prescriber, anesthesiologist or hematologist. The safest recommendation may involve continuing therapy, pausing it, changing the surgical scope or postponing the operation. No technique—including Deep Plane—overrides systemic risk.
Planning care in Brazil
Medication review begins before travel and is confirmed during the in-person and anesthesia assessments. Major facial procedures are performed at Hospital São José. Flight clearance depends on recovery and mobility, not a fixed holiday itinerary.
The bilingual Belvivere Concierge assists with accommodation, transport and appointments. Hormone prescribing and VTE prevention remain medical decisions.
This article is educational and does not replace advice from the prescribing clinician, surgeon, anesthesiologist or hematologist.
